2 news items
Cytokinetics Reports First Quarter 2024 Financial Results
CYTK
8 May 24
quarter of 2024 or a marketing authorisation application for aficamten in the European Union in the fourth quarter of 2024, our ability
Cytokinetics Reports Fourth Quarter 2023 Financial Results
CYTK
27 Feb 24
authorisation application for aficamten in the European Union, our ability to obtain approval of our marketing authorisation application
- Prev
- 1
- Next